KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 143 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $432,000 | -30.0% | 22,537 | -78.1% | 0.02% | -40.0% |
| Q2 2019 | $617,000 | +634.5% | 102,937 | +613.9% | 0.04% | +600.0% |
| Q1 2019 | $84,000 | -79.6% | 14,418 | -67.1% | 0.01% | -80.8% |
| Q4 2018 | $411,000 | -30.7% | 43,818 | +25.6% | 0.03% | -3.7% |
| Q3 2018 | $593,000 | -67.4% | 34,874 | -67.4% | 0.03% | -63.5% |
| Q2 2018 | $1,819,000 | +818.7% | 107,119 | +623.0% | 0.07% | +825.0% |
| Q1 2018 | $198,000 | -37.1% | 14,816 | -55.0% | 0.01% | -42.9% |
| Q4 2017 | $315,000 | +8.2% | 32,916 | +24.0% | 0.01% | -6.7% |
| Q3 2017 | $291,000 | -51.4% | 26,552 | -60.5% | 0.02% | -44.4% |
| Q1 2016 | $599,000 | -41.2% | 67,170 | -12.7% | 0.03% | -43.8% |
| Q4 2015 | $1,019,000 | -28.9% | 76,950 | -43.5% | 0.05% | -9.4% |
| Q3 2015 | $1,433,000 | +184.9% | 136,109 | +727.1% | 0.05% | +211.8% |
| Q1 2015 | $503,000 | +6.8% | 16,457 | +7.8% | 0.02% | -32.0% |
| Q1 2014 | $471,000 | – | 15,270 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,773,474 | $2,376,456 | 1.12% |
| AlphaCentric Advisors LLC | 1,125,000 | $1,507,500 | 0.86% |
| Tejara Capital Ltd | 1,077,388 | $1,443,700 | 0.82% |
| Palo Alto Investors LP | 5,675,876 | $7,605,674 | 0.72% |
| Birchview Capital, LP | 571,832 | $766,255 | 0.65% |
| Altium Capital Management LP | 740,000 | $991,600 | 0.52% |
| Avidity Partners Management LP | 8,298,570 | $11,120,084 | 0.45% |
| Worth Venture Partners, LLC | 445,981 | $597,615 | 0.36% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 561,955 | $753,020 | 0.23% |
| DAFNA Capital Management LLC | 192,678 | $258,189 | 0.08% |